Catania, July 24th 2020 – The University of Messina and SIFI, leading Italian pharmaceutical company in Ophthalmology, founded and strongly rooted in Sicily, announce they have signed a multi-year cooperation agreement to develop joint programmes for advanced education and research in many scientific areas of shared interest.
In particular UNIME and SIFI agreed to create a joint integrated Platform for research and training with the aim to strengthen synergies for the development of highly qualified professional profiles and to cultivate the required skills in order to manage challenging R&D programmes in the future.
Within this cooperation, the partners will have the chance to promote research programmes of common interest either through the exchange of respective highly qualified personnel, such as researchers, PhD graduates and students, and through the organization of university seminars and courses to provide the chance to share experiences.
“We do believe – declared Professor Salvatore Cuzzoccrea, Principal Dean of the University of Messina – that interaction within the productive system of Sicily can add value to our academic know-how catalysing technological transfer processes. This will lead to great benefits for this geographical area as well as greater opportunities for development, economic and occupational growth. We have a great attention for what we can receive, but also for what we can give, through agreements with important productive infrastructures.”
“SIFI has always developed innovative solutions for the treatment of the ocular diseases, both in the pharmaceutical and surgical fields” – said Fabrizio Chines, SIFI Chairman and CEO. “An essential feature of our strategy is the creation of Shared Value, through long-term investment in our geographical region for the development of future scientific expertise which will allow SIFI to go on with innovations in its business area. The agreement with the University of Messina fully adheres to this strategic vision.”
SIFI is the leading Italian ophthalmic company, focused on eye care since 1935 with the mission to improve people’s lives through meaningful innovation in Eye care. SIFI designs, manufactures and markets innovative pharmaceutical specialty products, nutraceuticals, surgical and medical devices. Headquartered in Catania, Sicily, SIFI operates directly in Italy, France, Spain, Romania, Turkey and Mexico with a staff of more than 400 people worldwide. Since June 2015, SIFI is backed by the private equity 21 Invest to support the company’s international expansion and portfolio development strategy. More information available at www.sifigroup.com.